Overall rank by patents
#10,106
of 50,000 tracked assignees
USPTO PatentsView assignee record - 31 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
According to USPTO PatentsView, Mueller ranks #10,106 of 50,000 tracked US assignees by granted-patent volume, with 31 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R10106 · US Corporation #10,106 · 31 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Mimi Hearing Technologies Gmbh (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
I D YOU · near
28 score
Hanmi Pharmaceutical · near
28 score
Mueller Sports Medic… · this assignee
28 score
Ortho Development · near
28 score
Tricorbraun · near
28 score
3D Lighting Innovati… · lowest
7 score
What this shows Mueller Sports Medicine, Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-NARROW, INNOV-THIN, CLAIMS-PAR, TYPE-USCORP, VEL-DOWN, BOOK-FULL. Volume places it #10,106 of 50,000; Innovation Score 27.7/100 sits in the top 76% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Mimi Hearing Technologies Gmbh (±0 grants).
Mueller Sports Medicine, Inc. has been granted 31 US utility patents between 2015 and 2025, placing Mueller Sports Medicine, Inc. at #10,106 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.3 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Mueller Sports Medicine, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Mueller sits between Mimi Hearing Technologies Gmbh (31 patents, rank #10,102) and Noble International, Inc. (31 patents, rank #10,110) - the closest US assignees by grant volume. The composite Innovation Score of 27.7/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 12 grants, compared with 18 in the 2015–2019 window, a -33% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Mueller Sports Medicine, Inc.'s 8.3 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 5 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Mimi Hearing Technologies GmbH
31 patents
Mission Therapeutics Limited
31 patents
Motion Pro Inc.
31 patents
Movius Interactive Corporation
31 patents
NANO DIMENSION TECHNOLOGIES, LTD.
31 patents
NATCO PHARMA LIMITED
31 patents
NISSIN ELECTRIC CO., LTD.
31 patents
NOBLE INTERNATIONAL, INC.
31 patents
Mueller Sports Medicine, Inc.
31 patents
What this shows Mueller holds 31 patents at rank #10,106, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #10,106 in granted patent volume.
Other assignees with the most granted patents in Mueller's primary technology class.
Two PlainPatent-derived peer sets for Mueller, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (28 here).
Mueller's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 Top 76% higher than 24% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 16.1% |
| 2016 | 4 | 12.9% |
| 2017 | 1 | 3.2% |
| 2018 | 3 | 9.7% |
| 2019 | 5 | 16.1% |
| 2020 | 3 | 9.7% |
| 2021 | 4 | 12.9% |
| 2022 | 2 | 6.5% |
| 2023 | 2 | 6.5% |
| 2024 | 1 | 3.2% |
| 2025partial year | 1 | 3.2% |
Top 5 of 5 technology areas
Overall rank by patents
#10,106
of 50,000 tracked assignees
27.7 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.